ID
33355
Beschrijving
Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01206881
Link
https://clinicaltrials.gov/show/NCT01206881
Trefwoorden
Versies (1)
- 06-12-18 06-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
6 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01206881
Eligibility Breast Cancer NCT01206881
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Cancer Other
Datatype
boolean
Alias
- UMLS CUI [1]
- C1707251
Beschrijving
Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschrijving
Disease Study Subject Participation Status Contraindicated | Condition Study Subject Participation Status Contraindicated
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C1444657
- UMLS CUI [2,1]
- C0348080
- UMLS CUI [2,2]
- C2348568
- UMLS CUI [2,3]
- C1444657
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Breast Cancer NCT01206881
- StudyEvent: Eligibility
C0333348 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C0456389 (UMLS CUI [2,2])
C0521317 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C2348568 (UMLS CUI [1,2])
C1444657 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444657 (UMLS CUI [2,3])
C0006147 (UMLS CUI [2])